Cas 1201908-67-9,(3S,3aS,6S,6aR)-6-hydroxyhexahydrofuro[3,2-b]furan-3-yl 4-methylbenzenesulfonate

1201908-67-9

Post Buying Request

Basic information

Product Name: (3S,3aS,6S,6aR)-6-hydroxyhexahydrofuro[3,2-b]furan-3-yl 4-methylbenzenesulfonate
Synonyms: (3S,3aS,6S,6aR)-6-hydroxyhexahydrofuro[3,2-b]furan-3-yl 4-methylbenzenesulfonate
CAS NO:1201908-67-9
Molecular Formula:
Molecular Weight: 300.332
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: (3S,3aS,6S,6aR)-6-hydroxyhexahydrofuro[3,2-b]furan-3-yl 4-methylbenzenesulfonate(CAS DataBase Reference)
NIST Chemistry Reference: (3S,3aS,6S,6aR)-6-hydroxyhexahydrofuro[3,2-b]furan-3-yl 4-methylbenzenesulfonate(1201908-67-9)
EPA Substance Registry System: (3S,3aS,6S,6aR)-6-hydroxyhexahydrofuro[3,2-b]furan-3-yl 4-methylbenzenesulfonate(1201908-67-9)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1201908-67-9(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1201908-67-9 Suppliers

Recommended suppliers

1201908-67-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1201908-67-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,0,1,9,0 and 8 respectively; the second part has 2 digits, 6 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1201908-67:
(9*1)+(8*2)+(7*0)+(6*1)+(5*9)+(4*0)+(3*8)+(2*6)+(1*7)=119
119 % 10 = 9
So 1201908-67-9 is a valid CAS Registry Number.

1201908-67-9Upstream product

1201908-67-9Downstream Products

1201908-68-0 monotosylate-5-isoidide 2-(tetrahydropyran-2-yl)

1201908-67-9Relevant academic research and scientific papers

MONOFLUORINATED DERIVATIVES OF DIANHYDROHEXITOLS AND PROCESSES FOR MAKING THE SAME

-

Paragraph 0046; 0047, (2014/01/08)

Novel monofluoro analogs of isosorbide, isomannide and isoidide are described, together with processes for making such monofluoro analogs.

Isosorbide-based cholinesterase inhibitors; replacement of 5-ester groups leading to increased stability

Dillon, Gerald P.,Gaynor, Joanne M.,Khan, Denise,Carolan, Ciaran G.,Ryder, Sheila A.,Marquez, Juan F.,Reidy, Sean,Gilmer, John F.

experimental part, p. 1045 - 1053 (2010/04/26)

Isosorbide-2-carbamate-5-esters are highly potent and selective butyrylcholinesterase inhibitors with potential utility in the treatment of Alzheimer's Disease (AD). They are stable in human plasma but in mouse plasma they undergo hydrolysis at the 5-ester group potentially attenuating in vivo potency. In this paper we explore the role of the 5-position in modulating potency. The focus of the study was to increase metabolic stability while preserving potency and selectivity. Dicarbamates and 5-keto derivatives were markedly less potent than the ester class. The 2-benzylcarbamate-5-benzyl ether was found to be potent (IC50 52 nM) and stable in the presence of mouse plasma and liver homogenate. The compound produces sustained moderate inhibition of mouse butyrylcholinesterase at 1 mg/kg, IP.

Copper-Catalyzed vs thermal step growth polymerization of starch-derived α-w-alkyne dianhydrohexitol stereoisomers: to click or not to click?

Besset, Celine,Binauld, Sandra,Ibert, Mathias,Fuertes, Patrick,Pascault, Jean-Pierre,Fleury, Etienne,Bernard, Julien,Drockenmuller, Eric

scheme or table, p. 17 - 19 (2011/09/14)

The synthesis of α-azide-ω-alkyne 1,4:3,6-dianhydrohexitols with controlled stereochemistry from starch-derived isosorbide, isomannide, and isoidide as well as a detailed study of their polyaddition by CuAAC in solution or by catalyst and solvent-free 1,3

Stereospecific method for the preparation of dioxa-bicyclooctane compounds

-

Page/Page column 24, (2009/12/27)

This invention relates to a new method for the stereospecific thiocarboxylation of organic compounds for the preparation of compounds according to formula (I): wherein a compound of formula (II): is reacted with a compound of formula (IIIa) or (IIIb): the

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1201908-67-9